Tradename | Company | Number | Date | Products |
---|---|---|---|---|
EDEX | Auxilium Pharmaceuticals | N-020649 RX | 1997-06-12 | 6 products, RLD, RS |
MUSE | Mylan | N-020700 RX | 1996-11-19 | 3 products, RLD, RS |
PROSTIN VR PEDIATRIC | Mylan | N-018484 RX | 1982-01-01 | 1 products, RLD, RS |
CAVERJECT | Mylan | N-020379 RX | 1995-07-06 | 3 products, RLD, RS |
CAVERJECT IMPULSE | Mylan | N-021212 RX | 2002-06-11 | 2 products |
Brand Name | Status | Last Update |
---|---|---|
caverject | New Drug Application | 2023-03-24 |
caverject impulse | New Drug Application | 2023-01-27 |
edex | New Drug Application | 2022-07-11 |
muse | New Drug Application | 2018-04-25 |
muse health hand sanitizer | OTC monograph not final | 2022-04-26 |
muse health hand sanitizer - fragrance free | OTC monograph not final | 2022-04-27 |
prostin | New Drug Application | 2022-10-03 |
prostin vr pediatric | 2006-04-20 | |
secret muse vita blue sun | OTC monograph not final | 2018-06-04 |
Code | Description |
---|---|
J0270 | Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
J0275 | Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Induced labor | D007751 | — | — | — | 1 | 3 | 3 | 4 | 11 |
Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | 1 | 2 | 1 | 1 | 5 | 9 |
Cervical ripening | D020070 | — | — | — | 1 | 2 | 1 | 1 | 5 |
Liver failure | D017093 | HP_0001399 | K72.9 | — | 1 | — | 1 | 1 | 3 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | — | 1 | 2 | 3 |
Obstetric labor complications | D007744 | — | — | — | 1 | 1 | 1 | 1 | 3 |
Arterial occlusive diseases | D001157 | EFO_0009085 | — | 1 | — | 1 | 1 | — | 3 |
Postpartum hemorrhage | D006473 | — | O72 | — | — | — | 2 | 1 | 3 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 1 | 1 | — | 2 |
Ischemia | D007511 | EFO_0000556 | — | — | 1 | — | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | — | 1 | 1 | — | 2 | 4 |
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | 1 | — | 1 | 2 |
Hemorrhage | D006470 | MP_0001914 | R58 | — | 1 | 1 | — | — | 2 |
Heart failure | D006333 | HP_0001635 | I50 | — | — | 1 | — | 1 | 2 |
Anemia | D000740 | HP_0001903 | D64.9 | — | — | 1 | — | — | 1 |
Transient tachypnea of the newborn | D059245 | — | P22.1 | — | — | 1 | — | — | 1 |
Maternal obesity | D000079262 | — | — | — | — | 1 | — | — | 1 |
Hepatic veno-occlusive disease | D006504 | — | K76.5 | — | 1 | 1 | — | — | 1 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | 1 | — | — | 1 |
Labor pain | D048949 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | 2 | — | — | 1 | 3 |
Covid-19 | D000086382 | — | U07.1 | — | 1 | — | — | 1 | 2 |
Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | — | 1 | — | — | 1 | 2 |
Chronic chemical and drug induced liver injury | D056487 | EFO_1000905 | — | 2 | 2 | — | — | — | 2 |
Respiratory insufficiency | D012131 | HP_0002093 | J96.9 | — | 2 | — | — | — | 2 |
Newborn respiratory distress syndrome | D012127 | — | P22 | — | 2 | — | — | — | 2 |
Actinic keratosis | D055623 | — | L57.0 | — | 2 | — | — | — | 2 |
Extracorporeal membrane oxygenation | D015199 | — | — | — | 1 | — | — | — | 1 |
Psoriasis | D011565 | EFO_0000676 | L40 | — | 1 | — | — | — | 1 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Congenital heart defects | D006330 | HP_0001627 | Q24.9 | 1 | — | — | — | 1 | 2 |
Acne vulgaris | D000152 | EFO_0003894 | L70 | 1 | — | — | — | — | 1 |
Cardiovascular diseases | D002318 | HP_0001626 | — | 1 | — | — | — | — | 1 |
Retained placenta | D018457 | — | O72.0 | 1 | — | — | — | — | 1 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | — | — | — | 2 | 2 |
Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | — | — | — | 2 | 2 |
Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | — | — | — | — | 2 | 2 |
Chronic pain | D059350 | HP_0012532 | — | — | — | — | — | 2 | 2 |
Coronary artery disease | D003324 | — | I25.1 | — | — | — | — | 1 | 1 |
Platelet aggregation | D010974 | GO_0070527 | — | — | — | — | — | 1 | 1 |
Penile neoplasms | D010412 | — | C60 | — | — | — | — | 1 | 1 |
Raynaud disease | D011928 | EFO_1001145 | I73.0 | — | — | — | — | 1 | 1 |
Rosacea | D012393 | — | L71 | — | — | — | — | 1 | 1 |
Sleep | D012890 | GO_0030431 | — | — | — | — | — | 1 | 1 |
Drug common name | Alprostadil |
INN | alprostadil |
Description | Prostaglandin E1 is a prostaglandins E. It has a role as a platelet aggregation inhibitor, a vasodilator agent, an anticoagulant and a human metabolite. It is a conjugate acid of a prostaglandin E1(1-). |
Classification | Small molecule |
Drug class | vasodilators (undefined group); prostaglandins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O |
PDB | — |
CAS-ID | 745-65-3 |
RxCUI | — |
ChEMBL ID | CHEMBL495 |
ChEBI ID | 15544 |
PubChem CID | 5280723 |
DrugBank | DB00770 |
UNII ID | F5TD010360 (ChemIDplus, GSRS) |